Pharmaceutical Microbiology 2014 will aim to provide unique industry insights from major pharmaceutical companies, academia and senior scientists involved in contamination and control, microbiology regulation, rapid microbiology methods and sterile manufacturing specialists to discuss regulation, preparations for auditing, inspection processes plus much more
The speaker line-up includes leading experts from Merial Sas (Sanofi), Medlmmune, AstraZeneca, Pfizer, former MHRA Inspector from Pharmaceutical Solution Ltd, FDA, Battelle, Genzyme, GSK, and Johnson & Johnson.
Pharmaceutical Microbiology 2014 will provide attendees with:
Regulatory body representation and updates from two FDA presentations – what to expect from inspection, how to prepare your lab, and how to rectify situations when things go wrong.
Insights into cutting edge rapid methods and how to safely implement the technology with unique insights from Battelle, Pfizer and Genzyme
Specialist advice on contamination control and risk management to minimise costs and maximise efficiency with case studies from AstraZeneca, Medlmmune and Merial Sas (Sanofi)
Discussions on topics which include objectionable organisms, viral contaminations, update on the pharmacopeias, and quality by design from Johnson & Johnson and GSK
Case studies and experiences with expert speakers and delegates from across the UK, USA, and Europe.
For further details visit the conference homepage at http://www.smi-
20 - 21 January 2014
Marriott Regents Park Hotel, London UK